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1607-551X/Copyright ª 2014, KaohsiuAbstract This study investigated the relationships among intraocular pressure (IOP), nitric
oxide (NO) levels, and aqueous flow rates in experimental ocular hypertension models. A to-
tal of 75 rabbits were used. One of four different materials [i.e., a-chymotrypsin, latex mi-
crospheres (Polybead), red blood cell ghosts, or sodium hyaluronate (Healon GV)] was
injected into the eyes of the 15 animals in each experimental group; the remaining 15 rabbits
were reserved for a control group. The IOP changes in the five groups were recorded on post-
induction Days 1e3, Day 7, Day 14, Day 30, Day 60, Day 90, and Day 120. On postinduction Day
7, the dynamics and NO levels in the aqueous humor were recorded. Significant IOP elevations
were induced by a-chymotrypsin (p < 0.01) and Polybead (p < 0.01) on each postinduction
day. In the red blood cell ghosts model, significant elevations (p < 0.01) were found on post-
induction Days 1e3; Healon GV significantly elevated IOP (p < 0.01) on postinduction Day 1
and Day 2. On postinduction Day 7, the aqueous humor NO levels increased significantly in the
models of a-chymotrypsin, Polybead, and red blood cell ghosts (all p < 0.01), while the
aqueous flow rates were significantly reduced in the models of a-chymotrypsin and Polybead
(p < 0.005). Persistent ocular hypertension models were induced with a-chymotrypsin and
Polybead in the rabbits. The Polybead model exhibited the characteristic of an increasedeclare no conflicts of interest.
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Glaucoma is a major cause of irreversible vision loss
worldwide and is considered to be a disease with progres-
sive optic neuropathy. Elevated intraocular pressure (IOP)
is a major risk factor for developing glaucomatous optic
neuropathy. Thus, lowering IOP is recognized as an effec-
tive glaucoma treatment [1]. In the past, various animal
models have been used to investigate the pharmacology
and pathophysiology of glaucoma, particularly the effects
of elevated IOP [2].
The study of animal models for different types of glau-
coma has not been highly successful. Most studies have
utilized rabbits, or to a lesser extent subhuman primates,
such as monkey species [2]. Rabbits exhibit an inherited
congenital glaucoma, and normotensive rabbits and rabbits
with different forms of experimental glaucoma have
frequently been investigated, particularly when screening
drugs to lower IOP [3]. According to Gelatt et al [2], the
most common experimental models used to induce glau-
coma in rabbits include the following: water loading; in-
jection of red blood cell (RBC) ghosts; injection of
a-chymotrypsin; laser-induction; and steroid injections.
The water-loading model does not maintain an elevated IOP
(> 30 mmHg) or increase the duration of the elevated IOP.
In the models of RBC ghost-induced glaucoma, the elevated
IOP does not persist for > 3 months. In the a-chymotrypsin
model, a long-term period of elevated IOP (> 30 mmHg)
was achieved. However, a-chymotrypsin causes intense
iridocyclitis, intraocular inflammation, lens dislocation and
vitreous precipitates. Laser-induced glaucoma requires
additional laser equipment and carries the risk of inducing
phthisis bulbi. Steroid-induced glaucoma requires frequent
injections and is associated with serious systemic side ef-
fects. A novel model of experimental glaucoma or ocular
hypertension in rabbits is therefore necessary.
In the eyes, nitric oxide (NO) plays a vital role in the
pathogenesis of glaucoma and involves regulating the IOP
[4], modulating local ocular blood flow [5], and controlling
retinal ganglion cell death by apoptosis [6]. The excessive
production of NO in glaucomatous eyes is stimulated by the
expression of the inducible isoform of NO synthase [7]. It
has been demonstrated that excessive NO is produced in
the retina and optic disc of rats with experimental glau-
coma and in the eyes of glaucoma patients [8e11]. In our
previous study, we also found that NO levels in the aqueous
humor (AH) differ in patients with different types of glau-
coma [10]. In the present study, one of our goals was to
compare four different experimental models based on their
IOP levels, AH NO levels, and aqueous flow rates. Another
goal was to elucidate the relationship between NO and
different ocular hypertension models.Materials and methods
Materials for glaucoma induction
The following materials were used to set up four different
glaucoma models: RBC ghosts, sodium hyaluronate (Healon
GV), a-chymotrypsin (Leurquin Co., Neuilly-sur-Marne,
France); latex microspheres (Polybead polystyrene, 2.5%
Solid-Polybead; PSI, Warrington, PA, USA); 10% sodium
fluorescein (NaFl) and tobramycin (Alcon Lab., Fort Worth,
TX, USA); and ketamine HCl, xylazine HC1, proparacaine
HC1 (Alcaine), and sodium phosphate buffer (pH 7.4; Sigma
Chemical Co., St. Louis, MO, USA). The New Zealand (NZW)
white rabbits were obtained from the National Taiwan
University Hospital Animal Center (Taipei, Taiwan).
Animal anesthesia and preparations for glaucoma
induction
A total of 75 eyes from 75 NZW white rabbits (weighing
2.5e3 kg, regardless of gender) were used in this in vivo
study. Each group was composed of 15 rabbits, which were
used for the material induction, and the remaining 15
rabbits were reserved for the control group. Animal care
and treatment complied with the guidelines of the Associ-
ation for Research in Vision and Ophthalmology governing
research animals. The NZW white rabbits were anes-
thetized with an intramuscular injection of ketamine HCl
(40 mg/kg) and xylazine HCl (8 mg/kg), and then, two eye
drops of 0.5% proparacaine HC1 (Alcaine) were placed in
the right eyes of the rabbits. After anesthesia, using two
30-G needles, we injected the four different materials into
the right eyes of the rabbits to induce glaucoma; the first
injection was into the anterior chamber through the limbus,
while the other drained the AH from the anterior chamber.
As the surgical wounds healed, infection was prevented by
administering topical tobramycin for 4 days [12]. The IOP
was initially measured after the inducing materials and was
recorded at regular intervals. The IOP changes in the five
groups were recorded on postinduction Days 1e3, Day 7,
Day 14, Day 30, Day 60, Day 90, and Day 120. On post-
induction Day 7, the dynamics and NO levels of the AH in
the individuals of each group were recorded.
IOP measurements
The IOPchanges in thefivegroupswere recordedonthe stated
postinduction days with a pneumotonometer (Langham, Cal-
ifornia, USA). Ocular hypertension induction (defined as IOP
>30mmHg) was compared between the induced eyes and the
control eyes according to their IOP levels [12].
Figure 1. Time distribution of the average intraocular
pressure values (mean  SD, nZ 15) of the New Zealand white
rabbits. The intraocular pressure changes in the five groups
were recorded on postinduction Days 1e3, Day 7, Day 14, Day
30, Day 60, Day 90, and Day 120. * p < 0.05.
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aqueous flow rates
On postinduction Day 7, we placed four drops of the NaFl
tracer into the center of the cornea and scanned the pupil
using fluorophotometry at regular intervals to observe the
AH dynamics. According to the method devised by Yablonski
[13], the measurement of the permeability (flow of the
fluorescent dye from the cornea to the anterior chamber)
was based upon fluorescent dynamics after topical appli-
cation of the fluorescent trace [14]. Mathematically, the
cornea and anterior chamber of the eye can be regarded as
two compartments that are separated by a semipermeable
membrane; if fluorescein is introduced into the smaller
compartment (the cornea), it will quickly diffuse through
the semipermeable membrane into the larger compart-
ment. Eventually, the concentrations between the two
compartments will reach equilibrium, with a constant ratio
between the two compartments. The following equations
describe this process.
The change in the concentration of the cornea:
dCc/dt Z Ka.ca (Ca e Cc) (1)
and the change in the concentration of the anterior
chamber:
dCa/dt Z Ko*Ca þ Ka.ca (Cc  Ca) (2)
where Cc and Ca are the fluorescein concentrations in the
cornea and the anterior chamber, respectively; Ko is the
transfer coefficient for anterior chamber loss; and Kc.ca
and Ka.ca are the transfer coefficients of fluorescein be-
tween the cornea and anterior chamber, and vice versa.
Where Vc and Vac refer to the volume of the cornea and the
volume of the anterior chamber, respectively, we have:
Vac Ka.ca Z Vc Kc.ca (3)
Measurement of aqueous flow
To reach the final concentration of 0.025% NaFl, we diluted
0.25 mL of the stock solution (10% w/v) with 9.75 mL of
25 mM sodium phosphate buffer (pH 7.4). The fluorescence
intensity was measured on a scanning fluorophotometer
(Fluorotron Master, OcuMetrics, Mountain View, CA, USA).
Fluorescence intensity was linearly related to a NaFl con-
centration between 1 nmol/L and 10,000 nmol/L. The NaFl
concentration was calculated from the fluorescence using a
standard calibration curve [15].
Detection of NO levels in the AH
On postinduction Day 7, the change in NO levels was
measured in the experimental and control eyes by obtain-
ing ocular humor via clear corneal paracentesis. To avoid
contact with blood vessels or damage to the iris or other
intraocular structures, 1 mL syringes with 30-gauge needles
were used. All samples were kept on ice and frozen at
70C until the protein extraction. Extraction was per-
formed in a 2-mL test tube by adding a double volume ofcold absolute alcohol, mixing thoroughly, incubating for 30
minutes at 4C, and then centrifuging for 6 minutes at
13,000 rpm (Denver Instrument, Arizona, USA). Finally, the
NO analyzer (Sievers 280 NOA, Sievers Inc., Boulder, CO,
USA) was used for the chemiluminescence method of
assaying the supernatants [10].
Statistical analysis
The t test for paired samples was used to determine the
level of statistical significance. A p value < 0.05 was
considered statistically significant.Results
Among the four materials used to induce the experimental
models of ocular hypertension, the a-chymotrypsin-induced
eyes (15 eyes of 15 rabbits) exhibited more serious in-
flammatory reactions than the other groups. On post-
induction Day 7, all 15 eyes in the a-chymotrypsin-induced
rabbit group exhibited serious intraocular inflammation. On
postinduction Day 120, six eyes in the a-chymotrypsin-
induced rabbit group exhibited lens dislocation.
The data showed that significant IOP elevations in the
eyes were induced with a-chymotrypsin (p < 0.01) and
Polybead (p < 0.01) on postinduction Days 1e3, Day 7, Day
14, Day 30, Day 60, Day 90, and Day 120 (Fig. 1 and Table 1).
Successful induction of ocular hypertension was achieved in
the eyes induced with a-chymotrypsin on postinduction
Days 1e3, Day 7, Day 14, Day 30, Day 60, Day 90, and Day
120 and in the eyes induced with Polybead on postinduction
Days 1e3, Day 7, Day 14, Day 30, and Day 60. Significant IOP
elevations were only found on postinduction Days 1e3 in
the eyes induced with RBC ghosts (p < 0.01) and on Days 1
and 2 with Healon GV (p < 0.01). After postinduction Day 7,
the rabbits induced with RBC ghosts and Healon GV failed to
achieve significant IOP elevations (Table 1).
On postinduction Day 7, the AH NO levels increased
significantly in the models induced with a-chymotrypsin
(p < 0.005), Polybead (p < 0.005), and RBC ghosts
(p < 0.01). No significant change was observed in the
Healon GV-induced models (Table 1). The aqueous flow
Table 1 The IOP, aqueous nitric oxide levels, and aqueous dynamics in the glaucomatous eyes of New Zealand white rabbits on
postinduction Day 7 after inducing the different materials (n Z 15).
Groups a-chymotrypsin Latex microspheres
(Polybead)
RBC ghost Healon GV Control eyes
Aqueous humor level
(mM)
135.5  14.5** 149.8  15.7** 87.6  6.1* 29.1  3.7 28.1  3.7
IOP
(mmHg)
31.3  3.9** 28.5  3.1** 15.9  2.5 15.1  2.1 15.1  2.3
Aqueous flow
Flow rate
(ul/min)
0.9  0.2** 1.4  0.3** 2.5  0.5 2.5  0.6 2.6  0.5
[AC]slope 0.0023  0.001* 0.003  0.001* 0.0047  0.001 0.005  0.0003 0.0044  0.001
[Cora]slope 0.0012  0.0002** 0.003  0.001* 0.0048  0.001 0.005  0.0001 0.0044  0.001
D (aver.) 5.9  1.8 6.9  1.8 6.6  1.5 4.5  1.1* 6.6  1.5
Ko (min1) 0.005  0.002 0.008  0.002 0.014  0.001 0.017  0.003 0.015  0.003
K(a.ca) min1 0.007  0.002** 0.009  0.004** 0.031  0.019 0.017  0.007* 0.031  0.019
K(c.ca) min1 0.002  0.0008* 0.003  0.001* 0.01  0.005 0.006  0.002 0.01  0.005
Data are presented as mean  SD.
* p < 0.01.
** p < 0.005.
AC Z anterior chamber; Cora Z cornea; D Z the flow equivalent to loss of fluorescein by diffusion; IOP Z intraocular pressure;
Ko Z the transfer coefficient for anterior chamber loss; K(c.ca) and K(a.ca) Z the transfer coefficients of fluorescein between the
cornea and anterior chamber, respectively; RBC Z red blood cell.
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induced with a-chymotrypsin (p < 0.005) and Polybead
(p < 0.005). No significant change was recorded in the RBC
ghost- and Healon GV-induced models (Table 1).Discussion
In the present study, we used four different materials to
induce an experimental model of ocular hypertension.
Significant IOP elevation was achieved in the rabbit models
induced with a-chymotrypsin and Polybead from post-
induction Day 1 to postinduction Day 120. Both models
caused ocular hypertension for at least 60 days. Neither
ghost RBCs nor Healon GV achieved significant IOP elevation
after postinduction Day 7. On postinduction Day 7, the AH
NO level increased significantly in the models induced with
a-chymotrypsin, Polybead, and RBC ghosts. Healon GV did
not cause an increased NO level in AH. The aqueous flow
rates were significantly decreased with a-chymotrypsin and
Polybead. Neither ghost RBCs or Healon GV resulted in a
significantly decreased aqueous rate. The a-chymotrypsin-
induced model also had more intraocular inflammation than
the other groups.
AH is released from the ciliary process and returned to
the venous system after passing through the trabecular
meshwork [16]. In our previous study, we found that the AH
NO level was higher in glaucomatous eyes than in non-
glaucomatous eyes [10]. The main reason for the higher
AH NO level in the glaucomatous eyes was proposed to be
the inflammatory reaction in response to the elevated IOP
[17]. Alternatively, Wang et al [18] believe that glaucoma is
a chronic disease and any increases in AH NO levels arise to
compensate for the impaired aqueous outflow that results
from pathogenic conditions. In rabbit models, it has been
demonstrated that NO synthase 2 is present in the oculartissue and that glutamate is elevated in the vitreous humor.
Excessive NO may be caused by elevated IOP [19e21]. In
our study, we found increased AH NO levels in a-chymo-
trypsin-, Polybead-, and RBC ghost-induced models. There
was no significant change in the AH NO level in the Healon
GV-induced model.
In our previous study [10], we found that neovascular
glaucoma (NVG) and acute angle-closure glaucoma (AACG)
patients had the highest NO levels in the AH. Recent studies
have demonstrated that NVG patients also have higher
levels of vascular endothelial growth factor (VEGF) in their
AH [22]. As VEGF is known to increase the release of NO
from human tissues [23], it is possible that the elevation of
VEGF leads to the higher levels of NO in the AH of NVG
patients. In addition, these patients also suffer from
breakdown of the bloodeaqueous barrier and chronic
inflammation in the anterior chamber, both of which might
also contribute to elevation of NO levels. The excessively
high NO levels in the AHs of NVG patients may indicate that
the pathology of NVG is usually complicated in diabetic
retinopathy, which is related to the development of neo-
vascularization in the iris and in the anterior chamber angle
of the eyes [24]. In AACG patients, inflammatory reactions
are usually present in the anterior chamber, which might
partially explain the elevated NO levels in the AH. Chiou
et al [11] have demonstrated significantly higher NO levels
in the AHs of AACG patients than in cataract patients. An
acute attack of glaucoma supposedly exacerbates the
inflammation, thereby inducing a higher NO level in the AH.
Thus, in NVG and AACG patients, we hypothesized that the
increased NO levels in the AH may be a manifestation of the
inflammatory status of the anterior chamber [10]. In our
study, both a-chymotrypsin and Polybead caused significant
IOP elevations and increased AH NO levels. The reason for
the increased AH NO levels in these models may be that
both materials caused various degrees of intraocular
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sphere, induced the experimental model with less intra-
ocular inflammation and tissue destruction than a-
chymotrypsin. In the current study, the Polybead model
exhibited the characteristics of high AH NO levels in the AH
and fewer complications; therefore, it may be an accept-
able experimental ocular hypertension model for the
further investigation of NVG and AACG.
In the past, many materials have shown the blockage of
the trabecular meshwork and elevated IOP in the eyes of
rabbit models, mimicking human glaucoma. However, dis-
advantages have existed in each of the various glaucoma and
ocular hypertension models, with major disadvantages
including a shorter period of IOP elevation and a lesser de-
gree of IOP elevation (< 30 mmHg). In our study, a-chymo-
trypsin and Polybead resulted in significant IOP elevations
from postinduction Day 1 to Day 120, whereas RBC ghosts
and Healon GV did not achieve significant IOP elevations
after postinduction Day 7. Bead microspheres were used to
induce experimental glaucoma by obstructing aqueous
outflow, and acute glaucoma was induced after the intra-
cameral or intravitreous injection of polystyrene beads in
the various animal models [25]. Weber et al [26] have pro-
posed that IOP elevation most likely results from the bead
obstruction of aqueous outflow, bead-induced swelling
within the trabecular meshwork, or infiltration of the
drainage channels by inflammatory cells. We found that the
Polybead-induced experimental model had significant IOP
elevations lasting for 120 days and IOP> 30mmHg lasting for
60 days. a-Chymotrypsin is a commonly used material for
inducing experimental glaucoma. However, induction with
a-chymotrypsin destroys the fibrin of the zonular fibers in
the anterior chamber, causing lens dislocation and serious
intraocular inflammation [21]. Such effects complicate the
intraocular condition and interfere with the investigation of
the pathology of glaucoma or drug mechanisms in experi-
mental models. Although the a-chymotrypsin-induced
model caused a longer period of IOP elevation than the
Polybead model, it also caused more severe intraocular
inflammation. Healon GV, a common material for inducing
IOP elevation in ocular surgery, was not a good experimental
model, according to our results. After injecting Healon GV
into the eyes, the IOP was elevated but slowly declined to
normal within 3 days. On Day 7 after the Healon GV induc-
tion, the experimental model showed no significant IOP
change. Compared to the other models, Healon GV resulted
in a poor effect on experimental ocular hypertension. The
RBC ghost model has been addressed previously, and it
confirmed the possibility of secondary glaucoma due to
trabecular obstruction [27,28]. According to the previous
study, the model easily produced IOP elevation for 7e36
days and was not associated with intraocular inflammation.
However, our study revealed that the IOP elevation induced
with the RBC ghost did not last for 7 days. This fact most
likely contributed to the variable results of the RBC ghost-
induced models. Interestingly, the AH NO levels were
significantly elevated in the RBC ghost-induced eyes despite
the lack of significant changes in IOP or aqueous flow rate.
We believe that RBC ghosts can still induce transient IOP
elevation in experimental eyes, while the effect of transient
IOP elevation caused the subsequent responses observed as
elevated AH NO levels on postinduction Day 7. In the presentstudy, the RBC ghost initially caused IOP elevation in the
experimental eyes, but the effect of IOP elevation did not
persist after 7 days. Hence, a longer period of higher IOP is
difficult for the RBC ghosts to achieve. We believe that the
RBC ghost may not impede the trabecular meshwork
entirely, and a longer period of elevated IOP may not be
easily achieved. In the present study, Healon GV- and RBC-
induced rabbit models initially caused elevated IOPs, but
the period of elevated IOP was shorter, leading us to suppose
that neither material caused a sufficient period of elevated
IOP or subsequent pathological changes.
In conclusion, we provided comparable results for the
IOP and AH NO levels and the aqueous flow rate for each of
the four different ocular hypertension models. According to
the present results, RBC ghost- and Healon GV- induced
models initially caused IOP elevation, but the change was
not significant after 7 days postinduction. a-Chymotrypsin
and Polybead were the best experimental models. In
addition, the Polybead-induced model exhibited fewer
complications than the a-chymotrypsin induced model.
Based on previous studies, Polybead exhibited similar fea-
tures (increased AH NO levels) in both NVG and AACG pa-
tients, and it may constitute a suitable model for
investigating these types of glaucoma.
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